|
|
(7R,14S)- dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid |
|
| CHEBI:138249 |
|
| (7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid |
|
| A dihydroxydocosahexaenoic acid that is (4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 7R- and 14S-positions. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
|
|
Molfile
XML
SDF
|
|
|
|
|
| InChI=1S/C22H32O4/c1-2-3-4-5-6-10-15-20(23)16-11-7-8-12-17-21(24)18-13-9-14-19-22(25)26/h3-4,6-13,16-17,20-21,23-24H,2,5,14-15,18-19H2,1H3,(H,25,26)/b4-3-,8-7+,10-6-,13-9-,16-11-,17-12+/t20-,21-/m0/s1 |
| HLHYXXBCQOUTGK-FHCQLJOMSA-N |
| C(CC/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@H](C/C=C\C/C=C\CC)O)(O)=O |
|
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
|
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
|
|
|
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
hepatoprotective agent
Any compound that is able to prevent damage to the liver.
|
|
View more via ChEBI Ontology
|
Outgoing
|
(7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid
(CHEBI:138249)
has functional parent
all-cis-docosa-4,7,10,13,16,19-hexaenoic acid
(CHEBI:28125)
(7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid
(CHEBI:138249)
has role
anti-inflammatory agent
(CHEBI:67079)
(7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid
(CHEBI:138249)
has role
hepatoprotective agent
(CHEBI:62868)
(7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid
(CHEBI:138249)
has role
human xenobiotic metabolite
(CHEBI:76967)
(7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid
(CHEBI:138249)
has role
specialised pro-resolving mediator
(CHEBI:140399)
(7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid
(CHEBI:138249)
is a
dihydroxydocosahexaenoic acid
(CHEBI:137348)
(7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid
(CHEBI:138249)
is a
secondary allylic alcohol
(CHEBI:134396)
|
|
|
(4Z,7R,8E,10E,12Z,14S,16Z,19Z)-7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid
|
|
(4Z,7R,8E,10E,12Z,14S,16Z,19Z)-7,14-dihydroxydocosahexaenoic acid
|
ChEBI
|
|
MaR1
|
ChEBI
|
|
maresin 1
|
ChEBI
|
|
21813987
|
Reaxys Registry Number
|
Reaxys
|
|
19103881
|
PubMed citation
|
Europe PMC
|
|
23504711
|
PubMed citation
|
Europe PMC
|
|
23663457
|
PubMed citation
|
Europe PMC
|
|
25036362
|
PubMed citation
|
Europe PMC
|
|
25369934
|
PubMed citation
|
Europe PMC
|
|
25409514
|
PubMed citation
|
Europe PMC
|
|
25539814
|
PubMed citation
|
Europe PMC
|
|
25655838
|
PubMed citation
|
Europe PMC
|
|
25777995
|
PubMed citation
|
Europe PMC
|
|
26196843
|
PubMed citation
|
Europe PMC
|
|
26196844
|
PubMed citation
|
Europe PMC
|
|
26617436
|
PubMed citation
|
Europe PMC
|
|
26667839
|
PubMed citation
|
Europe PMC
|
|
26878867
|
PubMed citation
|
Europe PMC
|
|
26881046
|
PubMed citation
|
Europe PMC
|
|
26915798
|
PubMed citation
|
Europe PMC
|
|
27398158
|
PubMed citation
|
Europe PMC
|
|
27531933
|
PubMed citation
|
Europe PMC
|
|
27559094
|
PubMed citation
|
Europe PMC
|
|
27613620
|
PubMed citation
|
Europe PMC
|
|
27799313
|
PubMed citation
|
Europe PMC
|
|
28042205
|
PubMed citation
|
Europe PMC
|
|
28079976
|
PubMed citation
|
Europe PMC
|
|
28182085
|
PubMed citation
|
Europe PMC
|
|
28188173
|
PubMed citation
|
Europe PMC
|
|
28218740
|
PubMed citation
|
Europe PMC
|
|
28703289
|
PubMed citation
|
Europe PMC
|
|
28751936
|
PubMed citation
|
Europe PMC
|
|
28768719
|
PubMed citation
|
Europe PMC
|
|
